On Aug. 7, OpenAI released GPT-5 — its latest AI model — which the company says includes significant improvements in addressing health-related questions.
The model performs considerably better than previous versions on HealthBench, a benchmark that uses real-world scenarios and physician-defined criteria, according to OpenAI.
GPT-5 is designed to serve as a thought partner, helping users understand their health, ask informed questions and prepare for conversations with medical providers.
The tool can tailor responses based on a user’s context, knowledge level and location, OpenAI said in an Aug. 7 news release.
The company emphasized that GPT-5 is not intended to replace medical professionals, but rather to support users in evaluating decisions and navigating care options.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
